Showing results (171-180 of 308) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|February 10, 2020
Automation Opportunities in Pharmacovigilance: An Industry SurveyRajesh Ghosh, Dieter Kempf, Angela Pufko, et al.Pharmaceutical Medicine|February 13, 2020
Factors Influencing the Generation of Evidence from Simple Data Held in International Rare Disease Patient RegistriesRavi Jandhyala, Solomon ChristopherPharmaceutical Medicine|February 13, 2020
Effective Market Exclusivity of New Molecular Entities for Rare and Non-rare DiseasesKirk W Kerr, Lukas J GlosPharmaceutical Medicine|February 29, 2020
Critical Factors Shaping Strategy Development of an Innovative Medicine in OncologyAndriy Krendyukov, Sreekanth GattuPharmaceutical Medicine|November 5, 2020
Strategies to Reduce Errors Associated with 2-Component VaccinesFarzana Samad, Samantha J Burton, Diana Kwan, et al.Pharmaceutical Medicine|March 18, 2020
US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)Thomas J Moore, Richard L Morrow, Colin R Dormuth, et al.Pharmaceutical Medicine|December 15, 2018
Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report ProcessingDanielle Abatemarco, Sujan Perera, Sheng Hua Bao, et al.Pharmaceutical Medicine|February 17, 2021
Regulatory Approval Scenario of Biosimilars in Pediatric Patients in the United States and European UnionSwetha Radhakrishna, Meghana Dahiya, Parag Pipalava, et al.Pharmaceutical Medicine|January 10, 2022
Digital Additional Risk Minimization Measures: An Exploratory Study Using Qualitative Feedback from Healthcare Professionals and Patients Across Six CountriesBarbara Da Silva-Tillmann, Marie-Claire Wilson, Hetal Doshi, et al.Pharmaceutical Medicine|September 13, 2022
Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and GeroprotectionKingsley C Mbara, Nikita Devnarain, Peter M O OwiraPageof 31